Shanghai Tofflon Science Tech (300171) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.006x

Based on the latest financial reports, Shanghai Tofflon Science Tech (300171) has a cash flow conversion efficiency ratio of 0.006x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥47.30 Million ≈ $6.92 Million USD) by net assets (CN¥8.09 Billion ≈ $1.18 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Shanghai Tofflon Science Tech worth for the company's overall valuation and market capitalisation.

Shanghai Tofflon Science Tech - Cash Flow Conversion Efficiency Trend (2007–2024)

This chart illustrates how Shanghai Tofflon Science Tech's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Shanghai Tofflon Science Tech Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai Tofflon Science Tech ranked by their cash flow conversion efficiency. Explore Shanghai Tofflon Science Tech cash flow quality index to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Vericel Corp Ord
NASDAQ:VCEL
0.042x
Alignment Healthcare LLC
NASDAQ:ALHC
-0.065x
Believe SAS
PA:BLV
0.049x
Jiangsu Ruitai New Energy Materials Co. Ltd.
SHE:301238
0.027x
Husqvarna AB (publ)
ST:HUSQ-B
0.146x
DTR Automotive
KO:007340
0.063x
Chongqing Three Gorges Water Conservancy and Electric Power Co Ltd
SHG:600116
0.048x
Fortress Income Fund Ltd
JSE:FFB
0.032x

Annual Cash Flow Conversion Efficiency for Shanghai Tofflon Science Tech (2007–2024)

The table below shows the annual cash flow conversion efficiency of Shanghai Tofflon Science Tech from 2007 to 2024. View 300171 share price today for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥8.05 Billion
≈ $1.18 Billion
CN¥880.61 Million
≈ $128.86 Million
0.109x +384.10%
2023-12-31 CN¥8.11 Billion
≈ $1.19 Billion
CN¥-312.38 Million
≈ $-45.71 Million
-0.039x -219.14%
2022-12-31 CN¥7.64 Billion
≈ $1.12 Billion
CN¥247.15 Million
≈ $36.17 Million
0.032x -89.42%
2021-12-31 CN¥4.48 Billion
≈ $655.32 Million
CN¥1.37 Billion
≈ $200.32 Million
0.306x +1.20%
2020-12-31 CN¥3.69 Billion
≈ $540.54 Million
CN¥1.12 Billion
≈ $163.28 Million
0.302x +119.46%
2019-12-31 CN¥3.24 Billion
≈ $474.49 Million
CN¥446.31 Million
≈ $65.31 Million
0.138x +93.23%
2018-12-31 CN¥3.12 Billion
≈ $456.14 Million
CN¥222.04 Million
≈ $32.49 Million
0.071x +950.96%
2017-12-31 CN¥3.09 Billion
≈ $451.60 Million
CN¥20.92 Million
≈ $3.06 Million
0.007x -81.07%
2016-12-31 CN¥3.00 Billion
≈ $438.97 Million
CN¥107.41 Million
≈ $15.72 Million
0.036x -24.96%
2015-12-31 CN¥2.95 Billion
≈ $431.38 Million
CN¥140.66 Million
≈ $20.58 Million
0.048x +131.95%
2014-12-31 CN¥2.68 Billion
≈ $391.66 Million
CN¥55.06 Million
≈ $8.06 Million
0.021x -85.39%
2013-12-31 CN¥2.41 Billion
≈ $352.36 Million
CN¥338.95 Million
≈ $49.60 Million
0.141x -9.76%
2012-12-31 CN¥2.23 Billion
≈ $325.86 Million
CN¥347.38 Million
≈ $50.83 Million
0.156x +185.77%
2011-12-31 CN¥2.08 Billion
≈ $304.19 Million
CN¥113.47 Million
≈ $16.60 Million
0.055x -84.69%
2010-12-31 CN¥331.97 Million
≈ $48.58 Million
CN¥118.39 Million
≈ $17.32 Million
0.357x -36.58%
2009-12-31 CN¥211.83 Million
≈ $31.00 Million
CN¥119.11 Million
≈ $17.43 Million
0.562x +47.46%
2008-12-31 CN¥147.32 Million
≈ $21.56 Million
CN¥56.17 Million
≈ $8.22 Million
0.381x +34.11%
2007-12-31 CN¥113.69 Million
≈ $16.64 Million
CN¥32.32 Million
≈ $4.73 Million
0.284x --

About Shanghai Tofflon Science Tech

SHE:300171 China Medical Instruments & Supplies
Market Cap
$1.73 Billion
CN¥11.83 Billion CNY
Market Cap Rank
#6730 Global
#1384 in China
Share Price
CN¥15.45
Change (1 day)
+7.59%
52-Week Range
CN¥10.77 - CN¥18.20
All Time High
CN¥59.76
About

Tofflon Science and Technology Group Co., Ltd. engages in the research, development, production, sales, and services of pharmaceutical equipment in China and internationally. It operates through four segments: Biotechnology, Preparation Equipment, Engineering, and Food Engineering. The company offers technological research, such as cell technology, complex preparation, injection, and OSD laborato… Read more